Skip Navigation

7th Annual Healthcare M&A and Business Development

September 9, 2009 - September 10, 2009

The global economic downturn has upended growth plans of virtually all companies in the healthcare sector. Credit has tightened, healthcare providers are under financial stress, device and diagnostic manufacturers are seeking to reduce production costs and more efficiently innovate, and pharmaceutical companies are shoring up product portfolios as patents expire. On top of this upheaval, the Obama Administration is preparing to create new regimes in healthcare
delivery, expenditures and reimbursements, with results that are difficult to predict.

Event Website: